Skip to main content
Premium Trial:

Request an Annual Quote

Nacalai to Distribute TriLink's Nucleic Acid Products in Asia

Premium

TriLink BioTechnologies this week announced that Nacalai, a manufacturing and marketing company based in San Diego, Calif., will distribute its modified nucleic acid products in Japan, Singapore, South Korea, and Taiwan.

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates, and CleanAmp PCR products for the diagnostic and original equipment manufacturer markets.

The agreement follows another distribution deal that TriLink signed last week that gave French distributor Tebu-Bio the rights to market its CleanAmp products for hot-start PCR in Europe [PCR Insider 01-14-2010].

Filed under

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.